# Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress

> **NCT01869556** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 105 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Ergot
- **DRUG:** Carboprost

## Key facts

- **NCT ID:** NCT01869556
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-04
- **Primary completion:** 2019-07-08
- **Final completion:** 2019-09-30
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2020-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01869556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01869556, "Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01869556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*